arrow
B

Bianca Mostert

Erasmus MC
H指数:25
被引数:2,488

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trials

肝动脉灌注泵化疗治疗不可切除的肝内胆管癌:四项临床试验的个体患者水平荟萃分析

2026-06-220
PRE
Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer

预测接受新辅助放化疗的食管癌患者术后肺炎的发生

2026-05-020
OAAI
The value of routine endoscopic ultrasound in patients with esophageal cancer undergoing active surveillance after neoadjuvant chemoradiotherapy

新辅助化放疗后行主动监测的食管癌患者常规内镜超声的价值

Endoscopy
IF12.8
2026-02-010
OA
Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial)

Panday, S.S.G.G.; van der Wilk, B.J.; Eyck, B.M.; Lagarde, S.M.; Rosman, C.; Noordman, B.J.; Valkema, M.J.; Bisseling, T.M.; Coene, P.-P.L.; van Det, M.J.; 等. 食管癌患者行主动监测与标准手术治疗健康相关生活质量比较(SANO试验). Br. J. Surg. 2025, 113, znaf286. [Google Scholar] [CrossRef] [PubMed]

2026-01-012
PRE
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials

根治性食管切除术后的条件无复发生存:11项试验的患者个体数据分析

2026-01-011
PRE
Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer

食管癌主动监测期间预测残余疾病和疾病进展的准确性

2025-10-230
OA
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survival

化疗放疗和手术切除后使用阿维单抗辅助治疗食管癌患者:一项真实世界总生存期的配对比较研究

2025-09-230
OAAI
ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinoma

ctDNA在食管鳞状细胞癌中检测新辅助化放疗后的残留病灶,并指导辅助治疗。

2025-09-050
OAAI
Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastases

I期研究:探讨腹腔内伊立替康联合全身性卡培他滨和奥沙利铂治疗胃腹膜转移患者的疗效

2025-08-280
PREAI
Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

评估病理完全缓解作为可切除食管癌总生存期替代终点的评价:基于III期试验个体患者数据的整合分析

2025-01-010
OAAI
Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study
2024-07-270
OAAI
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape (vol 27, 649, 2024)
2024-06-170
OAAI
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape Bertinoro Workshop, November 2022
2024-04-184
OAAI